The pharmaceutical sector played a critical role during the pandemic. Moreover, the industry is predicted to grow with an ageing population and the rise of chronic diseases. According to Statista, global pharmaceutical revenue is expected to expand at a 5.4% CAGR to $1.44 trillion by 2027.
Furthermore, pharmaceutical businesses and vendors of AI technology have been increasing their affiliations and collaborations. Also, last year, U.S. healthcare facilities and providers spent $17.9 billion on cloud-based technologies; in 2026, that value is projected to increase to $29.15 billion. The adoption of emerging technologies is expected to boost the industry’s prospects.
